Post Profile






Estrogen signaling impacted immune response in cancer

(The Wistar Institute) New research from The Wistar Institute showed that estrogen signaling was responsible for immunosuppressive effects in the tumor microenvironment across cancer types. These findings pave the way for combining immunotherapeutic treatments with anti-estrogen drugs that may significantly extend survival.
read more

share

Related Posts


Many Targeted Cancer Therapies Suppress T Cell Immune Responses

Health : Newswise Medical News

New research from The Wistar Institute demonstrated that dozens of these targeted therapies suppressed the activity of T cells that could actually help fight tumors. While studying the FDA-approved targeted therapy trametinib, the r...

Ludwig researchers show that infecting just 1 tumor with a virus could boost the systemic effectiveness of cancer immunotherapy

Health : Medical News Today

A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherap...

Inhibiting macrophage MerTK signaling creates an innate immune response against cancer

Academics / General Science : ScienceDaily: Science Society

New evidence shows that MerTK macrophage action in the microenvironment that surrounds cancer cells blunts the immune response, allowing the tumor cell to grow and metastasize.

New anti-cancer strategy mobilizes both innate and adaptive immune response

Academics / General Science : Science Codex

Though a variety of immunotherapy-based strategies are being used against cancer, they are often hindered by the inability of the immune response to enter the immunosuppressive tumor microenvironment and to effectively mount a respo...

Estrogen signaling impacted immune response in cancer

Diseases & Conditions / Cancer : ScienceDaily: Cancer

Estrogen signaling was responsible for immunosuppressive effects in the tumor microenvironment across cancer types, a new study has concluded. These findings pave the way for combining immunotherapeutic treatments with anti-estrogen...

Comments


Copyright © 2016 Regator, LLC